Harmony Biosciences Holdings (HRMY) Interest & Investment Income (2019 - 2026)

Harmony Biosciences Holdings has disclosed Interest & Investment Income across 8 years of filings, most recently posting $5.8 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $5.8 million, up 14.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.6 million (up 18.16% YoY), and the FY2025 annual result was $21.9 million, up 18.24% from the prior year.
• Interest & Investment Income came in at $5.8 million for Q1 2026 at Harmony Biosciences Holdings, down from $5.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $15.2 million in Q4 2022 to a low of -$4.2 million in Q1 2022.
• The 5-year median for Interest & Investment Income is $4.5 million (2024), against an average of $3.8 million.
• Peak annual rise in Interest & Investment Income reached 202.91% in 2023, while the deepest fall reached 73.07% in 2023.
• Harmony Biosciences Holdings' Interest & Investment Income stood at $15.2 million in 2022, then slumped by 73.07% to $4.1 million in 2023, then gained by 9.3% to $4.5 million in 2024, then jumped by 30.76% to $5.9 million in 2025, then retreated by 1.66% to $5.8 million in 2026.
• The last three Interest & Investment Income figures came in at $5.8 million (Q1 2026), $5.9 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.